Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Objective To evaluate the effect of the oral synthetic δ-9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. Design Randomised double blind placebo controlled crossover trial. Setting Outpatient clinic, University Hospital of Aarhus, Denmark. Participan...

Descripció completa

Dades bibliogràfiques

Publicat a:	BMJ
Autors principals:	Svendsen, Kristina B, Jensen, Troels S, Bach, Flemming W
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2004
Matèries:	Papers
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC498019/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15258006/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38149.566979.AE
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!